Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy
NCT00694863
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Idiopathic Membranous Nephropathy
Interventions
DRUG:
tetracosactide hexacetaat
Sponsor
Radboud University Medical Center
Collaborators
[object Object]